Genomic characterization of invasive meningococcal X isolates from Brazil, 1992–2022

• Ana Paula Cassiolato ^[1] ; Carlos Henrique Camargo ^[1] ; Maria Cristina Piccoli Cecconi ^[2] ; Sandra Christakis ^[2] ; Claudia Regina Gonçalves ^[1] ; Karoline Rodrigues Campos ^[1] ; Fabio Takenori Higa ^[3] ; Gabriela Andrade Pereira ^[4] ; Camile de Moraes ^[4] ; Ana Paula Silva de Lemos ^[1]
  1. [1] Instituto Adolfo Lutz
  2. [2] Public Health Laboratory
  3. [3] Institute Adolfo Lutz
  4. [4] Ministry of Health

  Mostrar afiliaciones +
• Localización: International microbiology: official journal of the Spanish Society for Microbiology, ISSN 1139-6709, Vol. 26, Nº. 3, 2023, págs. 611-618
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Introduction Invasive meningococcal disease (IMD) is a major health problem. Given the post-COVID-19 pandemic scenario with the loosening of the non-pharmacological measures to control the virus transmission and considering the observed global reduction of meningococcal vaccination coverage, an increase in IMD cases can be expected.

    Methodology Using whole-genome sequencing, we characterized six Neisseria meningitidis serogroup X (MenX) isolates recovered from IMD cases in Brazil in the last 30 years.

    Results The predominance (66.6%, 4/6) of ST2888 presenting fHbp 160, NHBA 129, NadA 21, and PorA 19,15 was found on isolates. Two novel STs, 15458 and 15477, were described.

    Conclusion This study describes the circulation of MenX lineage ST2888 in Brazil, previously reported only in Europe. Continuous universal surveillance is crucial to implement prompt public health measures aiming to prevent and control non-vaccine preventable serogroup X IMD cases.